Global Congestive Heart Failure Drugs Market Size & Outlook
Global congestive heart failure drugs market, 2018-2030 (US$M)
Related Markets
Global congestive heart failure drugs market highlights
- The global congestive heart failure drugs market generated a revenue of USD 6,150.0 million in 2021 and is expected to reach USD 20,230.7 million by 2030.
- The market is expected to grow at a CAGR (2022 - 2030) of 14.1% by 2030.
- In terms of segment, ace inhibitors accounted for a revenue of USD 2,022.1 million in 2021.
- Other Drug Types (Statins, including pipeline) is the most lucrative drug type segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2021.
- Country-wise, Saudi Arabia is expected to register the highest CAGR from 2022 to 2030.
Global data book summary
| Market revenue in 2021 | USD 6,150.0 million |
| Market revenue in 2030 | USD 20,230.7 million |
| Growth rate | 14.1% (CAGR from 2021 to 2030) |
| Largest segment | Ace inhibitors |
| Fastest growing segment | Other Drug Types (Statins, including pipeline) |
| Historical data covered | 2018 - 2020 |
| Base year for estimation | 2021 |
| Forecast period covered | 2022 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone antagonists, Inotropes, Other Drug Types (Statins, including pipeline) |
Other key industry trends
- In terms of revenue, the North America accounted for 37.8% of the global congestive heart failure drugs market in 2021.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Saudi Arabia is the fastest growing regional market and is projected to reach USD 151.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Congestive Heart Failure Drugs Market Scope
Congestive Heart Failure Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global congestive heart failure drugs market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to congestive heart failure drugs market will help companies and investors design strategic landscapes.
Ace inhibitors was the largest segment with a revenue share of 32.88% in 2021. Horizon Databook has segmented the Global congestive heart failure drugs market based on ace inhibitors, angiotensin 2 receptor blockers, beta blockers, diuretics, aldosterone antagonists, inotropes, other drug types (statins, including pipeline) covering the revenue growth of each sub-segment from 2018 to 2030.
- Global Congestive Heart Failure Drugs Drug Type Outlook (Revenue, USD Million, 2018-2030)
- ACE Inhibitors
- Angiotensin 2 Receptor Blockers
- Beta Blockers
- Diuretics
- Aldosterone antagonists
- Inotropes
- Other Drug Types (Statins, including pipeline)
- Global Congestive Heart Failure Drugs Distribution Channel Outlook (Revenue, USD Million, 2018-2030)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Reasons to subscribe to Global congestive heart failure drugs market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Global congestive heart failure drugs market databook
-
Our clientele includes a mix of congestive heart failure drugs market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of global-level data and insights on the Global congestive heart failure drugs market, including forecasts for subscribers. This global databook contains high-level insights into Global congestive heart failure drugs market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Global congestive heart failure drugs market report size, by regions, 2018-2030 (US$M)
Top 10 countries: Congestive heart failure drugs market report size, 2021 (US$M)
Global congestive heart failure drugs market report share, by drug type, 2021 & 2030 (%, US$M)
Congestive heart failure drugs market: Opportunity assessment by country
Global congestive heart failure drugs market, by region, 2021 (US$M)
| Drug Type | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | CAGR |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2,247.8 | 2,243.4 | 2,250.2 | 2,325.8 | 2,567.0 | 2,858.7 | 3,159.9 | 3,594.6 | 4,092.1 | 4,725.9 | 5,536.0 | 6,469.7 | 7,515.7 | 13.9% |
| Europe | 1,746.7 | 1,744.0 | 1,749.9 | 1,809.3 | 1,997.8 | 2,225.6 | 2,461.0 | 2,800.6 | 3,189.5 | 3,684.9 | 4,318.1 | 5,048.4 | 5,866.9 | 14.0% |
| Asia Pacific | 1,323.6 | 1,337.1 | 1,357.3 | 1,419.6 | 1,585.4 | 1,786.2 | 1,997.5 | 2,298.6 | 2,646.7 | 3,091.5 | 3,662.3 | 4,328.1 | 5,084.0 | 15.2% |
| Latin America | 379.4 | 377.1 | 376.8 | 387.9 | 426.4 | 473.0 | 520.7 | 589.9 | 668.8 | 769.2 | 897.2 | 1,044.1 | 1,207.8 | 13.5% |
| MEA | 211.5 | 207.5 | 204.4 | 207.4 | 224.7 | 245.4 | 266.0 | 296.6 | 330.8 | 374.0 | 428.7 | 490.0 | 556.4 | 11.6% |
| Overall | 5,909.0 | 5,909.1 | 5,938.6 | 6,150.0 | 6,801.3 | 7,588.9 | 8,405.2 | 9,580.3 | 10,927.8 | 12,645.5 | 14,842.3 | 17,380.4 | 20,230.7 | 14.2% |
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
